GREEN CROSS CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 18237
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13149
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 11156
 
  
 
C07K PEPTIDES 9127
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0368,175 PHARMACEUTICAL FORMULATION COMPRISING ANTI-EGFR ANTIBODYJan 15, 16Dec 28, 17[A61K]
2017/0189,473 COMPOSITION FOR PREVENTING OR TREATING STAPHYLOCOCCUS AUREUS INFECTIONMay 29, 15Jul 06, 17[A61K, C12P]
2017/0145,107 EPITOPES OF EPIDERMAL GROWTH FACTOR RECEPTOR SURFACE ANTIGENAND USE THEREOFFeb 06, 17May 25, 17[A61K, C12N, C07K]
2016/0311,772 COMPOUNDS AS TNIK, IKKEPSILON AND TBK1 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAMEApr 21, 16Oct 27, 16[C07D]
2016/0311,862 EPITOPE AND ITS USE OF HEPATITIS B VIRUS SURFACE ANTIGENJul 11, 16Oct 27, 16[C12N, C07K]
2016/0145,589 COMPOSITION AND FORMULATION COMPRISING RECOMBINANT HUMAN IDURONATE-2-SULFATASE AND PREPARATION METHOD THEREOFDec 21, 15May 26, 16[C12N]
2015/0231,220 EPITOPES OF EPIDERMAL GROWTH FACTOR RECEPTOR SURFACE ANTIGEN AND USE THEREOFMar 27, 13Aug 20, 15[A61K, G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9896672 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereofJun 16, 16Feb 20, 18[A61K, C12N]
9856216 Compounds as TNIK, IKKε and TBK1 inhibitors and pharmaceutical composition comprising sameApr 21, 16Jan 02, 18[C07D]
9683029 Antibody composition for prevention or treatment of mutant hepatitis B virus infectionJul 08, 13Jun 20, 17[A61K, C07K]
9415100 Epitope and its use of hepatitis B virus surface antigenJul 25, 11Aug 16, 16[A61K, A01K, C07K]
9371303 Diphenylmethane derivatives as SGLT2 inhibitorsJan 09, 15Jun 21, 16[A61K, C07D]
9340521 Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivativesMar 18, 13May 17, 16[C07D]
9249397 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereofJul 27, 15Feb 02, 16[A61K, C12N]
9206402 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereofJun 15, 12Dec 08, 15[A61K, C12N]
9200062 Human antibodies specifically binding to the hepatitis B virus surface antigenMay 21, 14Dec 01, 15[A61K, C07H, C12N, C07K]
9034921 Diphenylmethane derivatives as SGLT2 inhibitorsJun 01, 12May 19, 15[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0310,454 PHARMACEUTICAL COMPOSITION COMPRISING EXTRACT OF LONICERA JAPONICA FOR PREVENTION AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASEAbandonedNov 24, 11Nov 21, 13[A61K, A23L]
2013/0236,442 IDURONATE-2-SULFATASE AND USE THEREOFAbandonedNov 12, 10Sep 12, 13[C12N]
2013/0217,672 (+)-3-HYDROXYMORPHINAN-BASED POLYCYCLE DERIVATIVESAbandonedMay 13, 11Aug 22, 13[C07D]
8309584 Sulfur containing pyrazole-heterocycle derivatives as cannabinoid CB1 receptor antagonistsExpiredSep 25, 08Nov 13, 12[A61K, C07D, A61P]
2012/0122,848 (+)-3-HYDROXYMORPHINAN DERIVATIVES AS NEUROPROTECTANTSAbandonedJul 28, 10May 17, 12[A61K, C07D, A61P]
8178551 Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson'S disease prevention or treatmentExpiredMar 07, 08May 15, 12[A61K, C07D]
2012/0108,495 Method of Inhibiting Smooth Muscle Cell Proliferation by Using Reconstituted HDLAbandonedOct 25, 11May 03, 12[A61K, A61P]
2010/0260,712 USE OF HUMAN ANTIBODY CAPABLE OF NEUTRALIZING HEPATITIS B VIRUS FOR THE PREVENTION OR TREATMENT OF HEPATITIS B VIRUS INFECTIONAbandonedNov 21, 08Oct 14, 10[A61K, A61P, C07K]
2008/0262,066 Azole Derivatives as Cannabinoid CB1 Receptor AntagonistsAbandonedApr 18, 08Oct 23, 08[A61K, C07D, A61P]
2008/0207,704 HETEROARYL-IMIDAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTSAbandonedFeb 27, 07Aug 28, 08[A61K, C07D]
2008/0207,705 Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor AntagonistsAbandonedFeb 27, 08Aug 28, 08[A61K, C07D, A61P]
2008/0081,815 Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonistsAbandonedSep 29, 06Apr 03, 08[A61K, C07D]
6084110 Stable vitamin C preparationExpiredOct 28, 98Jul 04, 00[C07D]
6021645 Freezing and cooling system and heat exchanger device for condensationExpiredJan 20, 98Feb 08, 00[F25B]
5856337 2-arylquinolines and process for producing the sameExpiredJan 24, 97Jan 05, 99[A61K, C07D]
5662931 Process for preparing liposome compositionExpiredAug 11, 95Sep 02, 97[A61K]
5409815 DNA's encoding signal peptidesExpiredFeb 16, 89Apr 25, 95[C07H, C12P]
5389538 Mutant human prourokinaseExpiredOct 06, 92Feb 14, 95[A61K, C12N]
5214214 Perfluoro branched alkyl ethers and emulsionsExpiredMar 30, 92May 25, 93[A61K, C07C]
5183658 Hantaan virus strain ROK84/105 and vaccine thereforExpiredNov 16, 89Feb 02, 93[A61K, C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.